Salmon DNA Ampoule Special Kit
28-day intensive skin care system featuring 12 individual 3ml vials infused with salmon-derived PDRN DNA extract, hyaluronic acid, and peptides.
infoResearch & Clinical Context
Intensive 28-day regenerative protocol for profound skin hydration and elasticity.
Mechanism & Biological Overview
Salmon DNA Ampoule Special Kit is an intensive 28-day skin regeneration system featuring 12 individual 3ml vials powered by salmon-derived polydeoxyribonucleotide (PDRN) extract. Combined with sodium hyaluronate, niacinamide, and multi-peptide compounds, this formulation stimulates fibroblast proliferation and extracellular matrix synthesis. It delivers deep cellular hydration, boosts elasticity, and promotes a smooth, glowing, youthful complexion.
Key Biological Highlights & Benefits
- checkSalmon-derived DNA (PDRN) for advanced cellular repair
- checkIntensive 28-day targeted protocol with 12 sealed glass vials
- checkPromotes collagen synthesis and skin elasticity
- checkSupports skin barrier recovery post-treatment
Scientific Literature Abstract
"Polydeoxyribonucleotide (PDRN) extracted from salmon DNA serves as a bioactive substrate for the purinergic A2A receptor pathway. This mechanism stimulates VEGF release, enhances fibroblast proliferation, and accelerates tissue remodeling without inducing immunological adverse reactions."
hubTarget Receptor Pathways
Frequently Asked Questions
What is PDRN and why is salmon DNA used?
PDRN (polydeoxyribonucleotide) derived from salmon sperm DNA shares high structural biocompatibility with human DNA, providing essential nucleotides that accelerate cellular healing and collagen regeneration.
How often should the 28-day kit be used?
The kit includes 12 vials (3ml each) designed to be used consistently across 4 weeks as daily concentrated ampoules or paired with weekly microneedling.
Explore Related Scientific Interventions
Semaglutide Protocol
A GLP-1 receptor agonist studied for appetite modulation and glycemic signaling pathways in metabolic health.
Tirzepatide Dual Agonist
Dual GIP and GLP-1 receptor agonist targeting complementary metabolic pathways for body composition and appetite research.
Retatrutide Triple Agonist
Triple receptor agonist (GIP, GLP-1, and Glucagon) studied for its potential effects on metabolic rate and lipid mobilization pathways.
Clinical & Legal Disclaimer
Medical Disclaimer: Information provided on this website is for educational and informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Product availability, indications, regulatory status, and suitability may vary. Any medical treatment should be considered with an appropriately qualified healthcare professional.
NOVAMET does not guarantee specific weight-loss, metabolic, or treatment outcomes.